INTRODUCTION AND OBJECTIVES: To determine the frequency of mutations in the beta-myosin heavy-chain gene (MYH7) in a cohort of patients with hypertrophic cardiomyopathy (HCM) and their families, and to investigate correlations between genotype and phenotype. METHODS: Single-strand conformation polymorphism analysis and sequencing of fragments with abnormal MYH7 gene mobility were carried out in 128 consecutive index patients with HCM. The phenotypes of patients with and without mutations were compared and the phenotypes of identified families were recorded. RESULTS: A total of 11 mutations were found in 13 families (10%); 7/11 had been previously described. The I736T mutation was found in three families and the A797T in two. One patient had two mutations (i.e., I736T and R787H). Mutations were more frequent in patients with a family history of sudden death (31%) and in those with severe hypertrophy (39% had a thickness > or = 30 mm). Mutations were found in 29 of 42 members of the 13 families, including six family members (20%) who were healthy carriers and aged < or = 36 years. Sudden death had occurred in eight members of four families: four in two families with the I736T mutation, one in a family with A797T, one in a family with R870H, and two in a family with A901P. CONCLUSIONS: MYH7 mutations were present in 10% of our families. Mutations were more frequent in patients with a family history of sudden death and in those with severe hypertrophy. Most mutations had been described previously. Some appeared in several families. For some mutations, the correlation between genotype and phenotype was stable, while for others, there were marked differences between the phenotypes of the index patients and their relatives, suggesting the presence of additional genetic factors that have yet to be identified.
INTRODUCTION AND OBJECTIVES: To determine the frequency of mutations in the beta-myosin heavy-chain gene (MYH7) in a cohort of patients with hypertrophic cardiomyopathy (HCM) and their families, and to investigate correlations between genotype and phenotype. METHODS: Single-strand conformation polymorphism analysis and sequencing of fragments with abnormal MYH7 gene mobility were carried out in 128 consecutive index patients with HCM. The phenotypes of patients with and without mutations were compared and the phenotypes of identified families were recorded. RESULTS: A total of 11 mutations were found in 13 families (10%); 7/11 had been previously described. The I736T mutation was found in three families and the A797T in two. One patient had two mutations (i.e., I736T and R787H). Mutations were more frequent in patients with a family history of sudden death (31%) and in those with severe hypertrophy (39% had a thickness > or = 30 mm). Mutations were found in 29 of 42 members of the 13 families, including six family members (20%) who were healthy carriers and aged < or = 36 years. Sudden death had occurred in eight members of four families: four in two families with the I736T mutation, one in a family with A797T, one in a family with R870H, and two in a family with A901P. CONCLUSIONS:MYH7 mutations were present in 10% of our families. Mutations were more frequent in patients with a family history of sudden death and in those with severe hypertrophy. Most mutations had been described previously. Some appeared in several families. For some mutations, the correlation between genotype and phenotype was stable, while for others, there were marked differences between the phenotypes of the index patients and their relatives, suggesting the presence of additional genetic factors that have yet to be identified.
Authors: Farbod Sedaghat-Hamedani; Elham Kayvanpour; Oguz Firat Tugrul; Alan Lai; Ali Amr; Jan Haas; Tanja Proctor; Philipp Ehlermann; Katrin Jensen; Hugo A Katus; Benjamin Meder Journal: Clin Res Cardiol Date: 2017-08-24 Impact factor: 5.460
Authors: Pradeep Natarajan; Nina B Gold; Alexander G Bick; Heather McLaughlin; Peter Kraft; Heidi L Rehm; Gina M Peloso; James G Wilson; Adolfo Correa; Jonathan G Seidman; Christine E Seidman; Sekar Kathiresan; Robert C Green Journal: Sci Transl Med Date: 2016-11-09 Impact factor: 17.956
Authors: G Purushotham; K Madhumohan; Mohammad Anwaruddin; Ha Nagarajaram; Vuppaladadhiam Hariram; Calambur Narasimhan; Murali D Bashyam Journal: Exp Clin Cardiol Date: 2010
Authors: María Isabel Rodríguez-García; Lorenzo Monserrat; Martín Ortiz; Xusto Fernández; Laura Cazón; Lucía Núñez; Roberto Barriales-Villa; Emilia Maneiro; Elena Veira; Alfonso Castro-Beiras; Manuel Hermida-Prieto Journal: BMC Med Genet Date: 2010-04-30 Impact factor: 2.103
Authors: Zeynep H Coban-Akdemir; Wu-Lin Charng; Mahshid Azamian; Ingrid S Paine; Jaya Punetha; Christopher M Grochowski; Tomasz Gambin; Santiago O Valdes; Bryan Cannon; Gladys Zapata; Patricia P Hernandez; Shalini Jhangiani; Harsha Doddapaneni; Jianhong Hu; Fatima Boricha; Donna M Muzny; Eric Boerwinkle; Yaping Yang; Richard A Gibbs; Jennifer E Posey; Xander H T Wehrens; John W Belmont; Jeffrey J Kim; Christina Y Miyake; James R Lupski; Seema R Lalani Journal: Am J Med Genet A Date: 2020-03-31 Impact factor: 2.802
Authors: Luis R Lopes; Anna Zekavati; Petros Syrris; Mike Hubank; Claudia Giambartolomei; Chrysoula Dalageorgou; Sharon Jenkins; William McKenna; Vincent Plagnol; Perry M Elliott Journal: J Med Genet Date: 2013-02-08 Impact factor: 6.318
Authors: Lu Han; Yang Li; Jason Tchao; Aaron D Kaplan; Bo Lin; You Li; Jocelyn Mich-Basso; Agnieszka Lis; Narmeen Hassan; Barry London; Glenna C L Bett; Kimimasa Tobita; Randall L Rasmusson; Lei Yang Journal: Cardiovasc Res Date: 2014-09-10 Impact factor: 10.787